Jínek T, Adamčík L, Duda M, Buzrla P, Škrovina M
Rozhl Chir. 2018 Spring;97(7):328-334.
Chylothorax after esophageal resection is an uncommon but serious complication with a reported incidence of 1-10%. It occurs after the injury of the thoracic duct or its tributaries. Chylothorax may cause an overall loss of several liters per day and may lead to dehydration, malnutrition and immunosuppression. Therapeutic approach has not been standardized. Prophylactic ligation of the thoracic duct during primary resection has been introduced to decrease the overall incidence of chylothorax. Its oncological benefit is unknown.
A retrospective single-center study of patients who underwent transthoracic esophagectomy from 2008-2016 for esophageal carcinoma at the Department of Surgery, Hospital Nový Jičín. 58 patients underwent transthoracic esophagectomy (Ivor-Lewis and McKeown). Prophylactic ligation of the thoracic duct was performed in 31 patients (53%). The incidence of chylothorax and the amount of harvested lymph nodes was analysed in the group with thoracic duct ligation (A PTDL 31 patients) and in the non-ligation group (B 27 patients).
Overall incidence of chylothorax after transthoracic esophagectomy was 3.4%. Chylothorax occurred in two men (type 3B) in the prophylactic group (6.5%) and it was not observed in the non-ligation group. Statistically significant difference was not confirmed (p=0,494). Chylous leak was successfully treated thoracoscopically and by thoracotomy with repeat ligation of the thoracic duct. Non-significantly more lymph nodes were harvested in the prophylactic group (18 A PTDL vs. 15 B, p=1).
Prophylactic ligation of the thoracic duct in our study did not reduce the incidence of chylothorax. Redo thoracotomy and redo thoracoscopy for chylothorax is feasible. In patients with high-output and long lasting leaks the indication for redo surgery should be early. Key words: chylothorax - esophageal resection - prophylactic thoracic duct ligation.
食管切除术后乳糜胸是一种罕见但严重的并发症,报道的发生率为1%-10%。它发生在胸导管或其分支受损后。乳糜胸可能导致每天数升的总体液丢失,并可能导致脱水、营养不良和免疫抑制。治疗方法尚未标准化。在初次切除术中预防性结扎胸导管已被引入以降低乳糜胸的总体发生率。其肿瘤学益处尚不清楚。
对2008年至2016年在新伊钦医院外科接受经胸食管癌切除术的患者进行一项回顾性单中心研究。58例患者接受了经胸食管癌切除术(艾弗-刘易斯和麦基翁术式)。31例患者(53%)进行了胸导管预防性结扎。分析了胸导管结扎组(A组,31例胸导管结扎患者)和未结扎组(B组,27例患者)的乳糜胸发生率和收获的淋巴结数量。
经胸食管癌切除术后乳糜胸的总体发生率为3.4%。预防性结扎组有两名男性(3B型)发生乳糜胸(6.5%),未结扎组未观察到乳糜胸。未证实有统计学显著差异(p = 0.494)。乳糜漏通过胸腔镜和开胸手术成功治疗,并再次结扎胸导管。预防性结扎组收获的淋巴结数量略多,但无统计学意义(A组18个 vs. B组15个,p = 1)。
在我们的研究中,胸导管预防性结扎并未降低乳糜胸的发生率。因乳糜胸行再次开胸和再次胸腔镜手术是可行的。对于高流量和长期漏液的患者,再次手术的指征应尽早。关键词:乳糜胸 - 食管切除术 - 胸导管预防性结扎